Methods of producing lipid-derived compounds and host cells thereof
The present disclosure relates to genetically engineered host cells and methods of producing a lipid-derived compound by employing such host cells. In particular embodiments, the host cell includes a first mutant gene encoding a cytoplasmic tRNA thiolation protein. Optionally, the host cell can include other mutant genes for decreasing fatty alcohol catabolism, decreasing re-importation of secreted fatty alcohol, or displaying other useful characteristics, as described herein.
1. An isolated, genetically engineered host cell comprising:
a first mutant gene that is a deletion of a gene encoding a cytoplasmic tRNA thiolation protein; and
one or more expressed nucleic acids encoding 1) a fatty acyl-CoA reductase, or 2) a thioesterase, a carboxylicacid reductase and an aldehyde reductase.
2. The host cell of claim 1 , wherein the cytoplasmic tRNA thiolation protein is cytoplasmic tRNA 2-thiolation protein 2.
3. The host cell of claim 1 wherein the cytoplasmic tRNA thiolation protein comprises a polypeptide sequence having at least 90% sequence identity to any one of the following SEQ ID NOs: 1, 3-8, 10-16 and 18-20.
4. The host cell of claim 1 , wherein the engineered host cell further comprises a second mutant gene comprising insertion of a nucleic acid encoding an acetyl-CoA carboxylase, thereby providing overexpression of the acetyl-CoA carboxylase.
5. The host cell of claim 4 , wherein the acetyl-CoA carboxylase comprises a polypeptide sequence having at least 90% sequence identity to SEQ ID NO:30.
6. The host cell of claim 1 , wherein the engineered host cell further comprises a second mutant gene comprising deletion of a nucleic acid encoding a lysophospholipid acyltransferase, a fatty alcohol oxidase, an aldehyde dehydrogenase, an isocitrate dehydrogenase, or a pyruvate decarboxylase.
7. The host cell of claim 6 , wherein the lysophospholipid acyltransferase comprises a polypeptide sequence having at least 90% sequence identity to SEQ ID NO: 31; the fatty alcohol oxidase comprises a polypeptide sequence having at least 90% sequence identity to SEQ ID NO: 32; the aldehyde dehydrogenase comprises a polypeptide sequence having at least 90% sequence identity to SEQ ID NO: 33 or SEQ ID NO: 36; the isocitrate dehydrogenase comprises a polypeptide sequence having at least 90% sequence identity to SEQ ID NO: 34; or the pyruvate decarboxylase comprises a polypeptide sequence having at least 90% sequence identity to SEQ ID NO: 35.
8. A method of producing a fatty alcohol, the method comprising:
incubating an isolated, genetically engineered host cell in a culture; and
isolating one or more fatty alcohols from the culture,
wherein the genetically engineered host cell comprises a first mutant gene that is a deletion of a gene encoding a cytoplasmic tRNA thiolation protein, and further one or more expressed nucleic acids encoding 1) a fatty acyl-CoA reductase, or 2) a thioesterase, a carboxylic acid reductase and an aldehyde reductase.
9. The method of claim 8 , said incubating comprises 0 to 2 μM of zinc, 0 to 20 μM of cobalt, 0 to 20 μM of copper and/or 0.5 to 5 g/L ammonium in the culture.
10. The method of claim 8 , wherein the host cell provides an increased amount of the one or more fatty alcohols, as compared to a corresponding control cell lacking deletion of the first mutant gene.
11. The method of claim 8 , wherein the cytoplasmic tRNA thiolation protein is cytoplasmic tRNA 2-thiolation protein 2.
12. The method of claim 8 , wherein the cytoplasmic tRNA thiolation protein comprises a polypeptide sequence having at least 90% sequence identity to any one of the following SEQ ID NOs: 1, 3-8, 10-16 and 18-20.
13. The method of claim 8 , wherein the host cell further comprises a second mutant gene comprising insertion of a nucleic acid encoding an acetyl-CoA carboxylase or a fatty alcohol reductase, thereby providing overexpression of the acetyl-CoA carboxylase or overexpression of the fatty alcohol reductase.
14. The method of claim 8 , wherein the host cell further comprises a second mutant gene comprising deletion of a nucleic acid encoding a lysophospholipid acyltransferase, a fatty alcohol oxidase, an aldehyde dehydrogenase, an isocitrate dehydrogenase, or a pyruvate decarboxylase.
15. The method of claim 8 , wherein the fatty alcohol comprises a structure of R′OH, in which R′ is a C4-32 aliphatic that is optionally substituted.